Page 97 - BH-2-2

Brain & Heart Lipomatous hypertrophy of the septum secundum associated with PFO

hypertrophy of the interatrial septum: A pathological and of two cases. J Transcat Intervent. 2020;28:eA20200003.
clinical approach. Int J Cardiol. 2007;121:4-8.
doi: 10.31160/JOTCI202028A20200003
doi: 10.1016/j.ijcard.2006.11.150 11. Takafuji H, Obunai K, Kato N, Honda M, Watanabe H.
8. Cheezum MK, Jezior MR, Carbonaro S, Villines TC. Lipomatous atrial septal hypertrophy and atrial septal defect with
Lipomatous hypertrophy presenting as superior vena cava rim deficiency. JACC Cardiovasc Interv. 2022;15(3):e31-e33.
syndrome. J Cardiovasc Comput Tomogr. 2014;8:250-251. doi: 10.1016/j.jcin.2021.09.040
doi: 10.1016/j.jcct.2014.04.005 12. Seemann A, Dorman S, Juliard JM. Platypnoea-orthodeoxia
9. Arbarello P, Maiese A, Bolino G. Case study of sudden syndrome due to a patent foramen oval with marked lipomatous
cardiac death caused by lypomatous hypertrophy of the hypertrophy. Arch Cardiovasc Dis. 2011;104:261-262.
interatrial septum. Med Leg J. 2012;80:102-104. doi: 10.1016/j.acvd.2010.10.010
doi: 10.1258/mlj.2012.012012 13. Lin CH, Balzer DT, Lasala JM. Defect closure in the
10. Fernandes FH, do Amaral LV, Borges PA, de Almeida e lipomatous hypertrophied atrial septum with the Amplatzer
França VE, Masson Silva JB, Gardenghi G. Patent foramen muscular ventricular septal defect closure device: A case
ovale closure with prosthesis for occlusion of atrial septal series. Catheter Cardiovasc Interv. 2011;78:102-107.
defect in lipomatous hypertrophy of atrial septum. Report doi: 10.1002/ccd.22858

Volume 2 Issue 2 (2024) 5 doi: 10.36922/bh.2190